Popular

Ready, Set, Act! Opportunities to Address Persistent Unmet Needs in Patients With HFrEF: A Case-Based Discussion
CME/CEReady, Set, Act! Opportunities to Address Persistent Unmet Needs in Patients With HFrEF: A Case-Based Discussion

Hypopigmentation in Atopic Dermatitis Patients with Skin of Color
Dermatology Hub: Neuroimmune NetworkHypopigmentation in Atopic Dermatitis Patients with Skin of Color

When Skin and Itch Do Not Match in Atopic Dermatitis
Dermatology Hub: Neuroimmune NetworkWhen Skin and Itch Do Not Match in Atopic Dermatitis

Reimagining Alzheimer's Care: The Advent of Subcutaneous Administration of Anti-Amyloid Therapy
CME/CEReimagining Alzheimer's Care: The Advent of Subcutaneous Administration of Anti-Amyloid Therapy
Programs

Continuous Glucose and Ketone Monitoring: Making Smarter Decisions in Diabetes
CME/CEContinuous Glucose and Ketone Monitoring: Making Smarter Decisions in Diabetes

INFINITY in Focus: Translating New Nonsteroidal MRA Evidence Into Cardiorenal Practice
NephrologyINFINITY in Focus: Translating New Nonsteroidal MRA Evidence Into Cardiorenal Practice

FINE-ONE Across the Ages: Evaluating nsMRA Evidence in CKD and Type 1 Diabetes
Diabetes and EndocrinologyFINE-ONE Across the Ages: Evaluating nsMRA Evidence in CKD and Type 1 Diabetes

Starting With Confidence: A Practical Framework for Amyloid-Targeting Therapy in Early Alzheimer’s Disease
CME/CEStarting With Confidence: A Practical Framework for Amyloid-Targeting Therapy in Early Alzheimer’s Disease

Engineering Safer Antithrombotic Strategies for Secondary Stroke Prevention
CME/CEEngineering Safer Antithrombotic Strategies for Secondary Stroke Prevention

Oral GLP-1 RA Therapy in Type 2 Diabetes and High Cardiovascular Risk
CME/CEOral GLP-1 RA Therapy in Type 2 Diabetes and High Cardiovascular Risk
Clinical Practice

Real-World Evidence: Effectiveness of Finerenone in Reducing UACR in Patients With CKD and Type 2 Diabetes
Diabetes and EndocrinologyReal-World Evidence: Effectiveness of Finerenone in Reducing UACR in Patients With CKD and Type 2 Diabetes

Navigating the Limitations of Current BD Therapies
MinuteCE®Navigating the Limitations of Current BD Therapies

Redefining Endocrine Therapy: The Evidence Behind Oral SERDs and PROTAC ER Degraders
MinuteCE®Redefining Endocrine Therapy: The Evidence Behind Oral SERDs and PROTAC ER Degraders

Patient Portal: Leveraging Technology to Improve Safety with Clinical Decision-Making for People with Diabetes
CME/CEPatient Portal: Leveraging Technology to Improve Safety with Clinical Decision-Making for People with Diabetes

LGMD in Focus: Early Diagnosis, Precision Subtyping, and Targeted Therapies
CME/CELGMD in Focus: Early Diagnosis, Precision Subtyping, and Targeted Therapies

ACACIA-HCM: What Do the Phase 3 Results Show?
CardiologyACACIA-HCM: What Do the Phase 3 Results Show?
Doctors Lounge

Humanoids in Healthcare: Extending the Reach of Surgical Expertise
The ConvergenceHumanoids in Healthcare: Extending the Reach of Surgical Expertise

The Science of Exceptions: Setting the Safety Bar for Clinical AI
The ConvergenceThe Science of Exceptions: Setting the Safety Bar for Clinical AI

“We have the opportunity to understand what happens when someone leaves the clinic,” says Dr. Rajiv Kumar of Apple and Stanford Medicine
The Convergence“We have the opportunity to understand what happens when someone leaves the clinic,” says Dr. Rajiv Kumar of Apple and Stanford Medicine

Engaging Patients and Caregivers About Digital Therapeutics
Medical Industry FeatureEngaging Patients and Caregivers About Digital Therapeutics
CME

When “Mild” Matters Most: Closing Clinical Gaps in Early Symptomatic Alzheimer’s Disease
CME/CE Broadcast ReplayWhen “Mild” Matters Most: Closing Clinical Gaps in Early Symptomatic Alzheimer’s Disease

Ambulatory Monitoring Approaches for PSVT: Which One and When?
MinuteCE®Ambulatory Monitoring Approaches for PSVT: Which One and When?

Sticking Points: Managing Injection Site Reactions From Long-Acting Injectable Medications for HIV Care
CME/CESticking Points: Managing Injection Site Reactions From Long-Acting Injectable Medications for HIV Care

The Next Frontier: Addressing Persistent Cognitive Impairment in Bipolar Disorder
MinuteCE®The Next Frontier: Addressing Persistent Cognitive Impairment in Bipolar Disorder

Navigating Treatment Selection After First-line CDK4/6 Inhibitor Progression
MinuteCE®Navigating Treatment Selection After First-line CDK4/6 Inhibitor Progression

The Sequencing Puzzle: Integrating Oral SERDs and PROTACs into the mBC Treatment Landscape
MinuteCE®The Sequencing Puzzle: Integrating Oral SERDs and PROTACs into the mBC Treatment Landscape
Industry Feature

Treatment Considerations in Ulcerative Colitis: Shared Decision-Making
Medical Industry FeatureTreatment Considerations in Ulcerative Colitis: Shared Decision-Making

Bowel Urgency as a Key Symptom in Ulcerative Colitis
Medical Industry FeatureBowel Urgency as a Key Symptom in Ulcerative Colitis

Bowel Urgency as a Key Symptom in Crohn’s Disease
Medical Industry FeatureBowel Urgency as a Key Symptom in Crohn’s Disease

Taking Action in Friedreich Ataxia From Diagnosis to Treatment
Medical Industry FeatureTaking Action in Friedreich Ataxia From Diagnosis to Treatment

Single-Port Robotics Improves Outcomes for Thoracic Surgery
Medical Industry FeatureSingle-Port Robotics Improves Outcomes for Thoracic Surgery

A Real-World CIDP Patient Journey: Perspectives From a Neuromuscular Specialist
Medical Industry FeatureA Real-World CIDP Patient Journey: Perspectives From a Neuromuscular Specialist















































































































































